Suppr超能文献

采用REPAP方案逆转肺泡蛋白沉积症治疗失败情况。

Reversal of PAP Failure With the REPAP Protocol.

作者信息

Krakow Barry, Ulibarri Victor A, McIver Natalia D, Yonemoto Carli, Tidler Alyssa, Obando Jessica, Foley-Shea Michelle R, Ornelas Jonathan, Dawson Spencer

机构信息

Sleep and Human Health Institute, Albuquerque, New Mexico.

Maimonides Sleep Arts and Sciences, Albuquerque, New Mexico.

出版信息

Respir Care. 2017 Apr;62(4):396-408. doi: 10.4187/respcare.05032. Epub 2017 Feb 21.

Abstract

BACKGROUND

Re-titrations, an atypical approach to reverse PAP failure, was investigated retrospectively.

METHODS

Application of our re-titration of PAP (REPAP) protocol in subjects with previous PAP failure assessed original technology (masks, modes, and pressures) in 273 subjects, of which 70% reported co-occurring psychiatric conditions. The REPAP protocol emphasized changes in pressure modes and settings to address expiratory pressure intolerance and residual breathing events; mask changes were facilitated. Objective sleep and breathing metrics and subjective post-titration ratings were analyzed in subsequent PAP users and non-users.

RESULTS

Following REPAP protocol (average follow-up = 2 y), 196 of 273 subjects with previous PAP failure were PAP users, and 77 were non-users. Previous PAP failure was attributed to technology factors, including pressure intolerance, mask discomfort, adaptation difficulties, and no benefits. At second opinion re-titration, mask changes resolved discomfort, mouth breathing, or leak (91.2% of sample); pressure mode changes resolved expiratory pressure intolerance (83.5%); and pressure setting changes decreased residual breathing events and improved air flow (96.7%), all of which were associated with renewed PAP use. PAP users showed objective sleep improvements on re-titrations and reported better sleep quality than non-users. Multiple logistic regressions showed 2 subjective, re-initiation predictors: (1) post-re-titration ratings of better sleep quality and (2) less anticipated difficulty in using PAP after initial or multiple re-titrations. User rates were significantly higher for subjects completing multiple ( = 158) versus one ( = 115) re-titration (80% vs 61%, = .001). In multiple re-titration subjects, PAP users showed significance or a trend for lower apnea-hypopnea index ( = .02, g = 0.48) and respiratory disturbance index ( = .07, g = 0.36) compared with non-users. Available user downloads averaged >5 h/night.

CONCLUSIONS

Technology-related problems due to mask discomfort/leak, pressure intolerance, and residual breathing events were associated with PAP failure in subjects seeking second opinions. Technological solutions (changes in masks, modes, and pressures) were addressed during REPAP protocol, after which 72% of subjects re-initiated PAP use. These technological interventions were associated with improved objective and subjective sleep variables and reversal of PAP failure.

摘要

背景

回顾性研究了重新滴定这一逆转持续气道正压通气(PAP)治疗失败的非典型方法。

方法

对273例先前PAP治疗失败的受试者应用我们的PAP重新滴定(REPAP)方案,评估原始技术(面罩、模式和压力),其中70%报告同时患有精神疾病。REPAP方案强调压力模式和设置的改变,以解决呼气压力不耐受和残余呼吸事件;方便更换面罩。对后续使用PAP和未使用PAP的受试者的客观睡眠和呼吸指标以及滴定后的主观评分进行分析。

结果

遵循REPAP方案(平均随访 = 2年),273例先前PAP治疗失败的受试者中,196例成为PAP使用者,77例未使用。先前PAP治疗失败归因于技术因素,包括压力不耐受、面罩不适、适应困难以及无益处。在二次滴定中,更换面罩解决了不适、口呼吸或漏气问题(占样本的91.2%);压力模式改变解决了呼气压力不耐受问题(83.5%);压力设置改变减少了残余呼吸事件并改善了气流(96.7%),所有这些都与重新使用PAP相关。PAP使用者在重新滴定后睡眠客观改善,且报告的睡眠质量优于未使用者。多项逻辑回归显示有2个主观的重新开始使用的预测因素:(1)重新滴定后睡眠质量评分更高,(2)在初次或多次重新滴定后使用PAP时预期困难更少。完成多次( = 158)重新滴定的受试者的使用率显著高于完成一次( = 115)重新滴定的受试者(80%对61%, = .001)。在多次重新滴定的受试者中,与未使用者相比,PAP使用者的呼吸暂停低通气指数( = .02,g = 0.48)和呼吸紊乱指数( = .07,g = 0.36)有显著差异或呈下降趋势。可用的使用者下载量平均每晚>5小时。

结论

在寻求二次意见的受试者中,面罩不适/漏气、压力不耐受和残余呼吸事件等与技术相关的问题与PAP治疗失败有关。在REPAP方案期间解决了技术问题(面罩、模式和压力的改变),此后72%的受试者重新开始使用PAP。这些技术干预与客观和主观睡眠变量的改善以及PAP治疗失败的逆转相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验